These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 33451759)
1. SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study. Rauber C; Tiwari-Heckler S; Pfeiffenberger J; Mehrabi A; Lund F; Gath P; Mieth M; Merle U; Rupp C Transplant Proc; 2021 May; 53(4):1112-1117. PubMed ID: 33451759 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests. van Dam P; Huizing M; Roelant E; Hotterbeekx A; De Winter FHR; Kumar-Singh S; Moons P; Amajoud Z; Vulsteke C; Croes L; Janssens A; Berneman Z; Prenen H; Meuris L; Vanden Berghe W; Smits E; Peeters M Eur J Cancer; 2021 May; 148():328-339. PubMed ID: 33773276 [TBL] [Abstract][Full Text] [Related]
3. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study. Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW; Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432 [TBL] [Abstract][Full Text] [Related]
4. Coronavirus Disease 2019 Associated Risk Score, Behavior, and Symptom Prevalence in German Transplant Recipients. Thieme CJ; Zgoura P; Todorova I; Babel D; Witzke O; Viebahn R; Halleck F; Bachmann F; Westhoff TH; Choi M; Babel N Transplant Proc; 2021 May; 53(4):1245-1248. PubMed ID: 33441257 [TBL] [Abstract][Full Text] [Related]
5. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort. Campos-Varela I; Len O; Villagrasa A; Márquez-Algaba E; Esperalba J; Dopazo C; Los-Arcos I; Antón A; Castells L Transpl Int; 2021 Oct; 34(10):1908-1913. PubMed ID: 34121244 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases. Mack D; Gärtner BC; Rössler A; Kimpel J; Donde K; Harzer O; Krutsch W; von Laer D; Meyer T Clin Microbiol Infect; 2021 Mar; 27(3):473.e1-473.e4. PubMed ID: 33285279 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Seroconversion in Children and Adults With Mild COVID-19. Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study. Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782 [TBL] [Abstract][Full Text] [Related]
10. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies. Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280 [TBL] [Abstract][Full Text] [Related]
11. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study. Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile. Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States. Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study. Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941 [TBL] [Abstract][Full Text] [Related]
18. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study. Al-Mughales JA; Al-Mughales TJ; Saadah OI Front Immunol; 2021; 12():705441. PubMed ID: 34539635 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441 [TBL] [Abstract][Full Text] [Related]
20. Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients. Silvano J; Ferreira F; Bustorff M; Nunes AT; Tavares I; Sobrinho Simões J; Ramos A; Cardoso MJ; Sampaio S; Pestana M Transplant Proc; 2021 May; 53(4):1180-1186. PubMed ID: 33419577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]